These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 24613527

  • 21. Adverse events associated with 2010 CSL and other inactivated influenza vaccines.
    Kelly HA, Skowronski DM, De Serres G, Effler PV.
    Med J Aust; 2011 Sep 19; 195(6):318-20. PubMed ID: 21929484
    [Abstract] [Full Text] [Related]

  • 22. Epidemiological study of severe febrile reactions in young children in Western Australia caused by a 2010 trivalent inactivated influenza vaccine.
    Armstrong PK, Dowse GK, Effler PV, Carcione D, Blyth CC, Richmond PC, Geelhoed GC, Mascaro F, Scully M, Weeramanthri TS.
    BMJ Open; 2011 May 30; 1(1):e000016. PubMed ID: 22021725
    [Abstract] [Full Text] [Related]

  • 23. NSW annual report describing adverse events following immunisation, 2010.
    Mahajan D, Campbell-Lloyd S, Cook J, Menzies RI.
    N S W Public Health Bull; 2011 Nov 30; 22(9-10):196-208. PubMed ID: 22060057
    [Abstract] [Full Text] [Related]

  • 24. Data mining for prospective early detection of safety signals in the Vaccine Adverse Event Reporting System (VAERS): a case study of febrile seizures after a 2010-2011 seasonal influenza virus vaccine.
    Martin D, Menschik D, Bryant-Genevier M, Ball R.
    Drug Saf; 2013 Jul 30; 36(7):547-56. PubMed ID: 23657824
    [Abstract] [Full Text] [Related]

  • 25. Post-marketing surveillance of adverse events following immunization with inactivated quadrivalent and trivalent influenza vaccine in health care providers in Western Australia.
    Regan AK, Tracey L, Gibbs R.
    Vaccine; 2015 Nov 17; 33(46):6149-51. PubMed ID: 26476362
    [Abstract] [Full Text] [Related]

  • 26. A prospective cohort study assessing the reactogenicity of pertussis and influenza vaccines administered during pregnancy.
    Regan AK, Tracey LE, Blyth CC, Richmond PC, Effler PV.
    Vaccine; 2016 Apr 29; 34(20):2299-304. PubMed ID: 27038132
    [Abstract] [Full Text] [Related]

  • 27. Comparative Postmarket Safety Profile of Adjuvanted and High-Dose Influenza Vaccines in Individuals 65 Years or Older.
    Pillsbury AJ, Fathima P, Quinn HE, Cashman P, Blyth CC, Leeb A, Macartney KK.
    JAMA Netw Open; 2020 May 01; 3(5):e204079. PubMed ID: 32369177
    [Abstract] [Full Text] [Related]

  • 28. Adverse Events Following Trivalent Inactivated Influenza Vaccination in Children: Analysis of the Vaccine Adverse Event Reporting System.
    Muhammad R, Haber P, Broder K, Leroy Z, Ball R, Braun MM, Davis RL, McMahon AW.
    Pediatr Infect Dis J; 2011 Jan 01; 30(1):e1-8. PubMed ID: 21042229
    [Abstract] [Full Text] [Related]

  • 29. Timeliness of signal detection for adverse events following influenza vaccination in young children: a simulation case study.
    Jacoby P, Glover C, Damon C, Fathima P, Pillsbury A, Durrheim D, Gold MS, Leeb A, Snelling T.
    BMJ Open; 2020 Mar 01; 10(2):e031851. PubMed ID: 32122906
    [Abstract] [Full Text] [Related]

  • 30. Febrile seizures after 2010-2011 influenza vaccine in young children, United States: a vaccine safety signal from the vaccine adverse event reporting system.
    Leroy Z, Broder K, Menschik D, Shimabukuro T, Martin D.
    Vaccine; 2012 Mar 02; 30(11):2020-3. PubMed ID: 22361303
    [Abstract] [Full Text] [Related]

  • 31. Serious adverse events rarely reported after trivalent inactivated influenza vaccine (TIV) in children 6-23 months of age.
    Rosenberg M, Sparks R, McMahon A, Iskander J, Campbell JD, Edwards KM.
    Vaccine; 2009 Jul 09; 27(32):4278-83. PubMed ID: 19450636
    [Abstract] [Full Text] [Related]

  • 32. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2009 Dec 11; 58(48):1351-6. PubMed ID: 20010511
    [Abstract] [Full Text] [Related]

  • 33. Annual report: surveillance of adverse events following immunisation in Australia, 2004.
    Lawrence GL, Boyd I, McIntyre PB, Isaacs D.
    Commun Dis Intell Q Rep; 2005 Dec 11; 29(3):248-62. PubMed ID: 16220860
    [Abstract] [Full Text] [Related]

  • 34. Monovalent H1N1 influenza vaccine safety in pregnant women, risks for acute adverse events.
    Nordin JD, Kharbanda EO, Vazquez-Benitez G, Lipkind H, Lee GM, Naleway AL.
    Vaccine; 2014 Sep 03; 32(39):4985-92. PubMed ID: 25045808
    [Abstract] [Full Text] [Related]

  • 35. Scientific investigations into febrile reactions observed in the paediatric population following vaccination with a 2010 Southern Hemisphere Trivalent Influenza Vaccine.
    Maraskovsky E, Rockman S, Dyson A, Koernig S, Becher D, Morelli AB, Barnden M, Camuglia S, Bodle J, Vandenberg K, Wang IM, Cristescu R, Loboda A, Citron M, Fontenot J, Hung D, Schoofs P, Pearse M.
    Vaccine; 2012 Dec 07; 30(51):7400-6. PubMed ID: 23063831
    [Abstract] [Full Text] [Related]

  • 36. Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: reports to VAERS.
    Halsey NA, Griffioen M, Dreskin SC, Dekker CL, Wood R, Sharma D, Jones JF, LaRussa PS, Garner J, Berger M, Proveaux T, Vellozzi C, Hypersensitivity Working Group of the Clinical Immunization Safety Assessment Network, Broder K, Setse R, Pahud B, Hrncir D, Choi H, Sparks R, Williams SE, Engler RJ, Gidudu J, Baxter R, Klein N, Edwards K, Cano M, Kelso JM.
    Vaccine; 2013 Dec 09; 31(51):6107-12. PubMed ID: 24120547
    [Abstract] [Full Text] [Related]

  • 37. Increased reactions to pediatric influenza vaccination following concomitant pneumococcal vaccination.
    Van Buynder PG, Frosst G, Van Buynder JL, Tremblay FW, Ross A, Jardine C, Fei BG.
    Influenza Other Respir Viruses; 2013 Mar 09; 7(2):184-90. PubMed ID: 22498052
    [Abstract] [Full Text] [Related]

  • 38. Annual report: Surveillance of adverse events following immunisation in Australia, 2011.
    Mahajan D, Cook J, Dey A, Macartney K, Menzies RI.
    Commun Dis Intell Q Rep; 2012 Dec 31; 36(4):E315-32. PubMed ID: 23330706
    [Abstract] [Full Text] [Related]

  • 39. Safety and immunogenicity of revaccination with reduced dose intradermal and standard dose intramuscular influenza vaccines in adults 18-64 years of age.
    Gorse GJ, Falsey AR, Johnson CM, Morrison D, Fried DL, Ervin JE, Greenberg DP, Ozol-Godfrey A, Landolfi V, Tsang PH.
    Vaccine; 2013 Dec 05; 31(50):6034-40. PubMed ID: 24055306
    [Abstract] [Full Text] [Related]

  • 40. Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled study.
    Englund JA, Walter E, Black S, Blatter M, Nyberg J, Ruben FL, Decker MD, GRC28 Study Team.
    Pediatr Infect Dis J; 2010 Feb 05; 29(2):105-10. PubMed ID: 19934787
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.